$1.18
0.032.61%
At close: -
$1.18
-0.00490-0.42%
After Hours: May 2, 9:02 AM EDT
Comments
Loading...
Evogene Analyst Ratings and Price Targets | NASDAQ:EVGN | Benzinga
Evogene Ltd has a consensus price target of $6.96 based on the ratings of 4 analysts. The high is $12 issued by Lake Street on August 23, 2024. The low is $1.85 issued by Alliance Global Partners on October 2, 2023. The 3 most-recent analyst ratings were released by Lake Street, Alliance Global Partners, and Lake Street on August 23, 2024, October 2, 2023, and August 18, 2023, respectively. With an average price target of $5.62 between Lake Street, Alliance Global Partners, and Lake Street, there's an implied 377.97% upside for Evogene Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Lake Street
Alliance Global Partners
Roth MKM
Aegis Capital
1calculated from analyst ratings
Analyst Ratings for Evogene
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 08/23/2024 | Buy Now | 921.19% | Lake Street | Ben Klieve40% | $30 → $12 | Maintains | Buy | Get Alert |
| 10/02/2023 | Buy Now | 57.43% | Alliance Global Partners | Ben Haynor36% | → $18.5 | Initiates | → Buy | Get Alert |
| 08/18/2023 | Buy Now | 155.3% | Lake Street | Ben Klieve40% | $20 → $30 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | 410.59% | Roth MKM | Brian Wright33% | $10 → $60 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 70.2% | Lake Street | Ben Klieve40% | → $20 | Initiates | → Buy | Get Alert |
| 09/12/2022 | Buy Now | 580.79% | Aegis Capital | Nathan Weinstein31% | $100 → $80 | Maintains | Buy | Get Alert |
| 09/02/2022 | Buy Now | 155.3% | Roth MKM | Brian Wright33% | $60 → $30 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Evogene (EVGN) stock?
The latest price target for Evogene (NASDAQ:EVGN) was reported by Lake Street on August 23, 2024. The analyst firm set a price target for $12.00 expecting EVGN to rise to within 12 months (a possible 916.95% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Evogene (EVGN)?
The latest analyst rating for Evogene (NASDAQ:EVGN) was provided by Lake Street, and Evogene maintained their buy rating.
When was the last upgrade for Evogene (EVGN)?
There is no last upgrade for Evogene
When was the last downgrade for Evogene (EVGN)?
There is no last downgrade for Evogene.
When is the next analyst rating going to be posted or updated for Evogene (EVGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evogene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evogene was filed on August 23, 2024 so you should expect the next rating to be made available sometime around August 23, 2025.
Is the Analyst Rating Evogene (EVGN) correct?
While ratings are subjective and will change, the latest Evogene (EVGN) rating was a maintained with a price target of $30.00 to $12.00. The current price Evogene (EVGN) is trading at is $1.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
